NCT06429150 2024-06-10Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or PlasmacytomaShenzhen Geno-Immune Medical InstitutePhase 1/2 Recruiting20 enrolled
NCT06435910 2024-06-10Engineered Dendritic Cell Vaccines for Multiple MyelomaShenzhen Geno-Immune Medical InstitutePhase 1 Recruiting10 enrolled